Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INTERCEPT Treated Platelets Stored for 6 or 7 Days
NCT02653443Phase 2Terminated
- Sponsor
- Cerus Corporation
- Start
- Dec 2015
- Primary completion
- May 2016
- Countries
- 1
01
Overview
A Phase 2 trial of INTERCEPT Platelets in Thrombocytopenia, sponsored by Cerus Corporation. Started Dec 2015; status: terminated.
02
Drugs
INTERCEPT Platelets
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT02653443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02653443.